C
Align Technology, Inc. ALGN
$176.12 $6.673.94% NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

Company Overview

Align Technology, Inc. is a global medical device company operating primarily in the orthodontics and digital dentistry industries. The company is best known for the Invisalign system, a clear aligner solution used to straighten teeth, and for its iTero intraoral scanners and digital orthodontic software. Align serves orthodontists, general practitioner dentists, and dental laboratories, generating revenue through product sales, recurring consumables, and software-related services.

Founded in 1997, Align Technology pioneered the commercial use of clear aligners as an alternative to traditional braces. The company achieved a major inflection point with the broader adoption of Invisalign in the early 2000s and has since expanded its portfolio to include digital scanning, treatment planning, and CAD/CAM software. Its differentiation is driven by a large proprietary aligner manufacturing platform, extensive clinical data, and deep integration across the digital orthodontic workflow.

Business Operations

Align operates through two reportable business segments: Clear Aligner and Systems and Services. The Clear Aligner segment includes Invisalign comprehensive, moderate, and express treatment products for teens and adults, which represent the majority of company revenue. The Systems and Services segment includes iTero scanners, related software, upgrades, and orthodontic CAD/CAM solutions, including those provided by exocad GmbH.

The company maintains vertically integrated operations, controlling aligner design, digital treatment planning, and manufacturing. Align sells directly to dental professionals globally and supports them through training, clinical education, and digital services. Key subsidiaries include exocad GmbH, which provides open-architecture dental design software widely used by laboratories and clinics, and regional sales and service entities across international markets.

Strategic Position & Investments

Align’s strategy focuses on expanding global adoption of Invisalign, increasing utilization among general practitioner dentists, and advancing end-to-end digital dentistry platforms. The company continues to invest heavily in automation, materials science, and software-driven treatment planning to improve clinical outcomes and operating efficiency.

A cornerstone investment was the acquisition of exocad GmbH, which significantly expanded Align’s presence in dental CAD/CAM software and strengthened its digital ecosystem. Align also invests in next-generation scanner hardware, AI-assisted treatment planning, and cloud-based collaboration tools, positioning the company at the intersection of orthodontics and digital healthcare technology.

Geographic Footprint

Align Technology is headquartered in North America (Tempe, Arizona) and operates globally across North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. The company generates a substantial portion of its revenue outside the United States, with particularly strong market presence in Europe and Asia-Pacific.

Manufacturing operations are primarily located in Mexico and China, while software development and administrative functions are distributed across the United States, Germany, and other international locations. Align’s global footprint supports both mature orthodontic markets and emerging regions with increasing demand for aesthetic dental solutions.

Leadership & Governance

Align Technology was co-founded by Zia Chishti, who played a central role in the development of clear aligner therapy and the early commercialization of Invisalign. The company is led by an executive team focused on long-term growth through innovation, clinical credibility, and digital integration across orthodontic and restorative dentistry.

Key members of leadership include:

  • Joseph Hogan – President and Chief Executive Officer
  • Zia Chishti – Co‑Founder
  • Tillmann Steinbrecher – Chief Executive Officer, exocad GmbH

The leadership philosophy emphasizes clinician-centric product development, disciplined capital allocation, and sustained investment in digital platforms to support scalable global growth.

Data complied by narrative technology. May contain errors

Top Tech Stocks
See All »
B
NVDA NASDAQ $181.93
B
AAPL NASDAQ $254.23
B
MSFT NASDAQ $399.41
Top Consumer Staple Stocks
See All »
B
WMT NASDAQ $125.08
B
Top Financial Stocks
See All »
B
B
JPM NYSE $286.89
B
V NYSE $308.46
Top Energy Stocks
See All »
B
ENB.TO TSX $73.47
B
ENB NYSE $54.05
Top Health Care Stocks
See All »
B
LLY NYSE $930.35
B
JNJ NYSE $238.11
B
AMGN NASDAQ $361.13
Top Real Estate Stocks
See All »
B
PLD NYSE $133.21